Background: LCP2 Protein in Immune Signaling

LCP2, also widely known as SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa), is a cytoplasmic scaffold/adapter protein encoded by the LCP2 gene. It is predominantly expressed in hematopoietic cells, with highest levels in T lymphocytes, natural killer (NK) cells, platelets, and mast cells. LCP2 functions as a central node in the signaling network downstream of the T cell receptor (TCR) and various Fc receptors.

Upon TCR engagement, the tyrosine kinase ZAP-70 phosphorylates the transmembrane adapter LAT, which recruits SLP-76 via the Grb2-family adapter Gads. Phosphorylated SLP-76 then nucleates a multi-protein complex that activates phospholipase C-γ1 (PLCγ1), leading to IP3 generation, Ca²⁺ flux, and ultimately NFAT-dependent gene transcription. SLP-76 also recruits Vav1 and Nck, coupling TCR signaling to actin cytoskeleton remodeling and integrin activation.

Loss-of-function studies in mice demonstrate that LCP2 is indispensable for T cell development beyond the CD4⁻CD8⁻ (double-negative) stage, underscoring its non-redundant role. Recombinant Human LCP2 Protein (rp370791) enables researchers to study these interactions in vitro, validate antibody specificity, and establish biochemical reconstitution systems.

Reagents, Equipment, and Safety

Reagents required:

• Recombinant Human LCP2 Protein (rp370791, Aladdin Scientific)
• Sterile, nuclease-free deionized water or reconstitution buffer as specified on the Certificate of Analysis (CoA)
• PBS (pH 7.4) or HEPES-buffered saline for dilution
• Carrier protein if required (e.g., 0.1% BSA, molecular biology grade) to stabilize dilute working stocks
• Appropriate assay-specific reagents (e.g., SDS-PAGE loading buffer, ELISA capture antibodies)

Equipment required:

• Calibrated micropipettes and low-protein-binding tips
• Microcentrifuge (≥10,000 × g capability)
• –80 °C ultra-low temperature freezer
• Laminar flow biosafety cabinet (for sterile work)
• Spectrophotometer or fluorometric microplate reader (for protein quantification)

Safety considerations:

Recombinant Human LCP2 Protein is a research-use-only (RUO) reagent not intended for diagnostic or therapeutic use. Handle with standard laboratory precautions: wear gloves, lab coat, and eye protection. Consult the Safety Data Sheet (SDS) before use. Avoid aerosol generation during reconstitution.

Step-by-Step Protocol: Reconstitution, Storage, and Handling

Step 1 — Retrieve and equilibrate. Remove the vial from –80 °C storage and allow it to equilibrate briefly at room temperature (RT, ~22 °C) for 5–10 minutes. Do not heat the vial.

Step 2 — Centrifuge. Briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) to collect lyophilized or precipitated material at the bottom before opening.

Step 3 — Reconstitute. Add the volume of sterile reconstitution buffer specified on the product CoA (typically sterile deionized water or PBS, pH 7.4) gently along the side of the vial. Do not add directly onto the pellet or vortex vigorously. Gently swirl or pipette mix until fully dissolved. If the protein is supplied in liquid form, proceed directly to the dilution step.

Step 4 — Verify reconstitution. Measure the absorbance at 280 nm (A₂₈₀) or use a Bradford/BCA assay to confirm protein concentration against the CoA-stated value. Acceptable recovery is typically ≥90% of the stated concentration.

Step 5 — Prepare working aliquots. Using low-protein-binding microtubes, prepare single-use aliquots at volumes appropriate for your experimental needs. Label clearly with protein name, concentration, lot number, date of reconstitution, and preparer initials.

Step 6 — Store correctly. Store working aliquots at –80 °C. For short-term use within 1 week, aliquots may be stored at 4 °C. Adding a carrier protein (0.1% BSA) is recommended when working concentrations are below 10 µg/mL to prevent adsorptive losses. Avoid repeated freeze-thaw cycles; each cycle may reduce functional activity.

Step 7 — Thaw properly. Thaw aliquots on ice or at 4 °C. Do not use a 37 °C water bath. After thawing, mix gently and centrifuge briefly before use.

Application Guidelines for Common Assay Formats

Western Blotting (WB): Recombinant Human LCP2 Protein can be used as a positive control to validate anti-LCP2 antibody performance. Load 50–200 ng per lane on a 10% SDS-PAGE gel. The expected apparent molecular weight is approximately 76 kDa, though SLP-76 frequently migrates anomalously on SDS-PAGE due to its high content of acidic residues.

ELISA (Sandwich or Capture): Use as a standard curve antigen or as a capture antigen to develop and validate LCP2-specific immunoassays. Coat at 1–4 µg/mL in carbonate buffer (pH 9.6) overnight at 4 °C. Optimize blocking (1–5% BSA or non-fat milk in PBST) and antibody concentrations empirically.

Co-Immunoprecipitation (Co-IP) and Pull-Down Assays: LCP2 protein is suited to study its interactions with binding partners such as Gads, Nck, ADAP, and PLCγ1. Pre-clear lysates with protein A/G beads, then incubate the recombinant protein with target proteins or cell lysates at 4 °C with gentle rotation for 2–4 hours.

In Vitro Kinase Assays: Use purified Recombinant Human LCP2 Protein as a substrate for ZAP-70 or Lck to map phosphorylation sites (Y113, Y128, Y145 in the acidic domain). Confirm phosphorylation by phospho-specific antibodies or mass spectrometry.

General guidance: Always include a no-protein negative control and a known positive control in each experiment. Pilot experiments to determine optimal protein concentrations for each new lot are strongly recommended, as specific activity may vary between production batches.

Troubleshooting and Quality Control

Problem: No band or faint band on Western blot.
Possible causes: Protein degradation due to improper storage or freeze-thaw cycling; insufficient antigen loading; antibody incompatibility.
Solutions: Verify storage conditions; increase loaded amount (up to 500 ng); confirm antibody recognizes recombinant vs. native protein; check that reducing vs. non-reducing conditions match the antibody's validated format.

Problem: Band at unexpected molecular weight.
Possible causes: SLP-76 is known to run anomalously on SDS-PAGE, appearing higher than its predicted molecular weight (~58 kDa calculated vs. ~76 kDa apparent). Post-translational modifications or incomplete denaturation may also shift migration.
Solutions: Compare with the CoA-provided expected band position; include a molecular weight ladder with well-characterized standards.

Problem: Low ELISA signal.
Possible causes: Sub-optimal coating concentration; protein adsorbed to tube or plate surfaces; antigen denaturation.
Solutions: Optimize coating concentration (1–4 µg/mL); use low-binding plates; add 0.1% BSA to protein dilution buffer.

Problem: Protein aggregation or precipitation.
Possible causes: Freeze-thaw damage; incompatible buffer pH; protein concentration too high.
Solutions: Centrifuge at 10,000 × g for 5 minutes at 4 °C before use; reduce protein concentration; ensure buffer pH is 7.0–7.5.

Quality Control checkpoints: Each lot of Recombinant Human LCP2 Protein should be accompanied by a CoA documenting purity (typically assessed by SDS-PAGE and/or HPLC), protein concentration, endotoxin level, and biological activity data where applicable. Contact Aladdin Scientific technical support if CoA values are not met.